Elizabeth A Regan, Katherine E Lowe, Barry J Make, David A Lynch, Gregory L Kinney, Matthew J Budoff, Song Shou Mao, Debra Dyer, Jeffrey L Curtis, Russell P Bowler, MeiLan K Han, Terri H Beaty, John E Hokanson, Elizabeth Kern, Stephen Humphries, Douglas Curran-Everett, Edwin J R van Beek, Edwin K Silverman, James D Crapo, James H Finigan
Background: Lung cancer screening (LCS) via chest computed tomography (CT) scans can save lives by identifying early-stage tumors. However, most smokers die of comorbid smoking-related diseases. LCS scans contain information about smoking-related conditions that is not currently systematically assessed. Identifying these common comorbid diseases on CT could increase the value of screening with minimal impact on LCS programs. We determined the prevalence of 3 comorbid diseases from LCS eligible scans and quantified related adverse outcomes...
July 24, 2019: Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation